ACUTE RESPIRATORY DISTRESS SYNDROME
Clinical trials for ACUTE RESPIRATORY DISTRESS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new ACUTE RESPIRATORY DISTRESS SYNDROME trials appear
Sign up with your email to follow new studies for ACUTE RESPIRATORY DISTRESS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New care pathway aims to save lives of ICU patients with lung failure
Disease control OngoingThis study tests a step-by-step care plan for patients with severe breathing failure (ARDS) who need a breathing machine. The plan uses proven treatments like protective ventilation, paralysis, and prone positioning. Researchers will see if following this plan helps patients surv…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: University of Calgary • Aim: Disease control
Last updated May 26, 2026 07:00 UTC
-
Stem cell infusion aims to repair lungs in ARDS patients
Disease control OngoingThis study tests whether a single infusion of mesenchymal stem cells (MSCs) can help people with acute respiratory distress syndrome (ARDS), a severe lung condition often seen in ICU patients, including those with COVID-19. First, researchers find a safe dose, then compare the st…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Belfast Health and Social Care Trust • Aim: Disease control
Last updated May 26, 2026 06:51 UTC
-
Promising ARDS drug trial pulled before it began
Disease control TerminatedThis study aimed to test a drug called IC14 in people with acute respiratory distress syndrome (ARDS), a severe lung condition. Participants would have received IC14 or a placebo for 4 days and been followed for 28 days. The trial was withdrawn before enrolling anyone, so no resu…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE2 • Sponsor: Implicit Bioscience • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
Immune booster study for severe pneumonia pulled before start
Disease control TerminatedThis study aimed to see if adding two immune therapies—a drug called nogapendekin alfa inbakicept and special immune cells (iNKT cells)—to standard care could help critically ill adults with severe pneumonia, sepsis, or lung failure recover. It was designed for adults in the ICU …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Stem cell trial for critical COVID patients withdrawn before starting
Disease control TerminatedThis study aimed to test the safety and effects of an experimental stem cell treatment (BX-U001) for adults hospitalized with severe COVID-19 pneumonia and serious breathing problems (ARDS). The trial was designed in two parts: first to find a safe dose, and then to compare that …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Baylx Inc. • Aim: Disease control
Last updated Mar 13, 2026 15:06 UTC
-
Could carbon monoxide gas help heal lungs? small trial tests safety
Symptom relief OngoingThis early-phase study tests whether low doses of inhaled carbon monoxide are safe for people with severe lung injury caused by sepsis or pneumonia. Only 5 adults will receive the gas through a breathing mask, and researchers will closely monitor side effects. The goal is to see …
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated May 26, 2026 06:44 UTC
-
Heart MRI reveals hidden dangers in young cancer patients after sepsis
Knowledge-focused OngoingThis pilot study at St. Jude Children's Research Hospital tests whether a heart MRI can be done safely within 10 days after sepsis in children with cancer, without needing anesthesia. It aims to find hidden heart inflammation or weakness that could affect recovery. The results wi…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 07:01 UTC
-
Severe COVID-19 lung scarring: how common and who is at risk?
Knowledge-focused OngoingThis study looks at 200 people with severe COVID-19 who needed intensive care to see how often they develop lung scarring (pulmonary fibrosis). Researchers will track their recovery, including time off a breathing machine and survival at 90 days, to understand risk factors and ou…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Sponsor: Hôpital Européen Marseille • Aim: Knowledge-focused
Last updated May 26, 2026 06:46 UTC
-
Researchers track emergency response to toxic attacks
Knowledge-focused ENROLLING_BY_INVITATIONThis study observes how medical teams care for people exposed to chemical, biological, radiological, nuclear, or explosive attacks. Researchers will track whether World Health Organization guidelines are followed during rescue and transport to hospitals. The goal is to improve em…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Sponsor: St. Justine's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC
-
Can a blister test help solve ARDS? new study explores Drug's effect on fluid leak
Knowledge-focused OngoingThis study looks at whether a drug called Racecadotril can reduce fluid leakage in skin blisters caused by a chemical. The blisters mimic some aspects of lung injury in ARDS, a severe condition where lungs fill with fluid. 48 healthy volunteers will receive either the drug or a p…
Matched conditions: ACUTE RESPIRATORY DISTRESS SYNDROME
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 26, 2026 06:45 UTC